Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2262797rdf:typepubmed:Citationlld:pubmed
pubmed-article:2262797lifeskim:mentionsumls-concept:C0027651lld:lifeskim
pubmed-article:2262797lifeskim:mentionsumls-concept:C0013216lld:lifeskim
pubmed-article:2262797lifeskim:mentionsumls-concept:C0026336lld:lifeskim
pubmed-article:2262797lifeskim:mentionsumls-concept:C0017638lld:lifeskim
pubmed-article:2262797lifeskim:mentionsumls-concept:C1844596lld:lifeskim
pubmed-article:2262797lifeskim:mentionsumls-concept:C1321489lld:lifeskim
pubmed-article:2262797lifeskim:mentionsumls-concept:C0796074lld:lifeskim
pubmed-article:2262797lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:2262797lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:2262797lifeskim:mentionsumls-concept:C1420740lld:lifeskim
pubmed-article:2262797lifeskim:mentionsumls-concept:C1513342lld:lifeskim
pubmed-article:2262797lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:2262797lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:2262797lifeskim:mentionsumls-concept:C1521827lld:lifeskim
pubmed-article:2262797pubmed:issue2lld:pubmed
pubmed-article:2262797pubmed:dateCreated1991-2-1lld:pubmed
pubmed-article:2262797pubmed:abstractTextA cell line, 497-P(1), derived from the VM spontaneous murine astrocytoma has been used to develop an in vitro therapeutic model of human glioma. In this study we describe the preparation of MTS from this cell line. The in vitro chemosensitivity of 497-P(1) MTS has been examined and compared to the sensitivity of the monolayer culture. BCNU and CCNU both produced growth delay in MTS at doses below the ID50 of the monolayer culture. MTS, however, were considerably more resistant to vincristine and procarbazine when compared to the monolayer culture.lld:pubmed
pubmed-article:2262797pubmed:languageenglld:pubmed
pubmed-article:2262797pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2262797pubmed:citationSubsetIMlld:pubmed
pubmed-article:2262797pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2262797pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2262797pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2262797pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2262797pubmed:statusMEDLINElld:pubmed
pubmed-article:2262797pubmed:monthOctlld:pubmed
pubmed-article:2262797pubmed:issn0167-594Xlld:pubmed
pubmed-article:2262797pubmed:authorpubmed-author:ThomasD GDGlld:pubmed
pubmed-article:2262797pubmed:authorpubmed-author:DarlingJ LJLlld:pubmed
pubmed-article:2262797pubmed:authorpubmed-author:BradfordRRlld:pubmed
pubmed-article:2262797pubmed:authorpubmed-author:REISD LDLlld:pubmed
pubmed-article:2262797pubmed:issnTypePrintlld:pubmed
pubmed-article:2262797pubmed:volume9lld:pubmed
pubmed-article:2262797pubmed:ownerNLMlld:pubmed
pubmed-article:2262797pubmed:authorsCompleteYlld:pubmed
pubmed-article:2262797pubmed:pagination105-14lld:pubmed
pubmed-article:2262797pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2262797pubmed:meshHeadingpubmed-meshheading:2262797-...lld:pubmed
pubmed-article:2262797pubmed:meshHeadingpubmed-meshheading:2262797-...lld:pubmed
pubmed-article:2262797pubmed:meshHeadingpubmed-meshheading:2262797-...lld:pubmed
pubmed-article:2262797pubmed:meshHeadingpubmed-meshheading:2262797-...lld:pubmed
pubmed-article:2262797pubmed:meshHeadingpubmed-meshheading:2262797-...lld:pubmed
pubmed-article:2262797pubmed:meshHeadingpubmed-meshheading:2262797-...lld:pubmed
pubmed-article:2262797pubmed:meshHeadingpubmed-meshheading:2262797-...lld:pubmed
pubmed-article:2262797pubmed:meshHeadingpubmed-meshheading:2262797-...lld:pubmed
pubmed-article:2262797pubmed:meshHeadingpubmed-meshheading:2262797-...lld:pubmed
pubmed-article:2262797pubmed:meshHeadingpubmed-meshheading:2262797-...lld:pubmed
pubmed-article:2262797pubmed:meshHeadingpubmed-meshheading:2262797-...lld:pubmed
pubmed-article:2262797pubmed:year1990lld:pubmed
pubmed-article:2262797pubmed:articleTitleThe VM model of glioma: preparation of multicellular tumour spheroids (MTS) and their response to chemotherapy.lld:pubmed
pubmed-article:2262797pubmed:affiliationGough-Cooper Department of Neurological Surgery, Institute of Neurology, Queen Square, London, United Kingdom.lld:pubmed
pubmed-article:2262797pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2262797pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2262797lld:pubmed